Viewing Study NCT06977061


Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2026-03-01 @ 2:44 AM
Study NCT ID: NCT06977061
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-16
First Post: 2025-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Sponsor: Queling Liu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module